Literature DB >> 18591953

A tale of two strategies. The moral imperative to tackle ageing.

Colin Farrelly1.   

Abstract

Mesh：

Year:  2008        PMID： 18591953      PMCID： PMC2475318          DOI： 10.1038/embor.2008.107

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  5 in total

1.  Normal functioning and the treatment-enhancement distinction.

Authors:  N Daniels
Journal:  Camb Q Healthc Ethics       Date:  2000       Impact factor: 1.284

Review 2.  Life extension, human rights, and the rational refinement of repugnance.

Authors:  A D N J de Grey
Journal:  J Med Ethics       Date:  2005-11       Impact factor: 2.903

3.  Resistance to debate on how to postpone ageing is delaying progress and costing lives. Open discussions in the biogerontology community would attract public interest and influence funding policy.

Authors:  Aubrey D N J de Grey
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

4.  Death as an unnatural process. Why is it wrong to seek a cure for aging?

Authors:  Arthur L Caplan
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

5.  Science fact and the SENS agenda. What can we reasonably expect from ageing research?

Authors:  Huber Warner; Julie Anderson; Steven Austad; Ettore Bergamini; Dale Bredesen; Robert Butler; Bruce A Carnes; Brian F C Clark; Vincent Cristofalo; John Faulkner; Leonard Guarente; David E Harrison; Tom Kirkwood; Gordon Lithgow; George Martin; Ed Masoro; Simon Melov; Richard A Miller; S Jay Olshansky; Linda Partridge; Olivia Pereira-Smith; Tom Perls; Arlan Richardson; James Smith; Thomas von Zglinicki; Eugenia Wang; Jeanne Y Wei; T Franklin Williams
Journal:  EMBO Rep       Date:  2005-11       Impact factor: 8.807
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.